SIGHT SCIENCES INC's ticker is and the CUSIP is 82657M105. A total of 69 filers reported holding SIGHT SCIENCES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $47,881 | -71.4% | 14,208 | -29.7% | 0.00% | – |
| Q2 2023 | $167,422 | +89.5% | 20,220 | +100.0% | 0.00% | – |
| Q1 2023 | $88,370 | +22.2% | 10,111 | +70.7% | 0.00% | – |
| Q4 2022 | $72,332 | -53.6% | 5,924 | -75.9% | 0.00% | – |
| Q3 2022 | $156,000 | +940.0% | 24,588 | +1740.4% | 0.00% | – |
| Q1 2022 | $15,000 | -77.6% | 1,336 | -65.2% | 0.00% | – |
| Q4 2021 | $67,000 | – | 3,840 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KCK LTD. | 4,776,232 | $42,938,000 | 60.33% |
| Sio Capital Management, LLC | 724,944 | $6,517,000 | 2.45% |
| D1 Capital Partners L.P. | 5,852,036 | $52,610,000 | 1.25% |
| PFM Health Sciences, LP | 776,281 | $6,979,000 | 0.27% |
| RTW INVESTMENTS, LP | 997,099 | $8,964,000 | 0.23% |
| ArrowMark Colorado Holdings LLC | 1,587,305 | $14,270,000 | 0.16% |
| Jackson Square Partners, LLC | 595,051 | $5,349,000 | 0.12% |
| Atom Investors LP | 11,181 | $101,000 | 0.04% |
| Bellevue Group AG | 294,606 | $2,649,000 | 0.04% |
| Orbimed Advisors | 200,000 | $1,798,000 | 0.03% |